Actively Recruiting

Phase Not Applicable
Age: 25Years - 65Years
All Genders
NCT07190170

Time Restricted Eating for WeIght LoSs MainTenance-2

Led by NYU Langone Health · Updated on 2025-12-26

110

Participants Needed

1

Research Sites

117 weeks

Total Duration

On this page

Sponsors

N

NYU Langone Health

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The TWIST 2.0 Study is a 12-month, 2-arm RCT in adults with recent weight loss. We will examine the efficacy of TRE on weight (Aim 1a) and fat mass (Aim 1b) regain, and describe changes in subjective appetite following a mixed-meal tolerance test (Exploratory).

CONDITIONS

Official Title

Time Restricted Eating for WeIght LoSs MainTenance-2

Who Can Participate

Age: 25Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 25 to 65 years old
  • At least 5% non-surgical weight loss in the last 3 months
  • Current BMI between 20.5 and 45 kg/m2
  • Own a smartphone or willing to use one for self-monitoring
  • Ability to provide signed informed consent and attend screening visit
Not Eligible

You will not qualify if you...

  • Pregnant, trying to get pregnant, or breastfeeding
  • Previous or planned bariatric surgery
  • History of eating disorder
  • Participation in another weight-management research study
  • Currently in a weight loss program other than this study
  • Using appetite suppressants
  • Following intermittent fasting or skipping meals
  • Eating window less than 11 hours and 59 minutes per day
  • Working overnight shifts more than once a week
  • Work involving travel across time zones
  • Taking medications affecting body weight or preventing TRE
  • Unable or unwilling to provide informed consent
  • Unable to participate meaningfully (e.g., uncorrected sight or hearing impairment)
  • Unwilling to accept randomization
  • Unable to log at least 2 meals into the app for 70% of the run-in period
  • Having type 1 or type 2 diabetes or other conditions preventing restricted eating
  • Narcolepsy
  • Losing more than 2.5 kg during run-in phase
  • Non-English speaking (app only available in English)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

NYU Langone Health

New York, New York, United States, 10016

Actively Recruiting

Loading map...

Research Team

C

Collin Popp

CONTACT

M

Margaret Curran

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here